[Molecular targeting therapy for chronic myeloid leukemia]. [electronic resource]
- [Rinsho ketsueki] The Japanese journal of clinical hematology Jan 2007
- 46-55 p. digital
Publication Type: Journal Article; Review
0485-1439
Antineoplastic Agents--therapeutic use Benzamides Clinical Trials, Phase II as Topic Dasatinib Fusion Proteins, bcr-abl--genetics Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Middle Aged Philadelphia Chromosome Piperazines--chemistry Protein Kinase Inhibitors--therapeutic use Pyrimidines--chemistry Thiazoles--chemistry